Financhill
Sell
49

NHC Quote, Financials, Valuation and Earnings

Last price:
$94.03
Seasonality move :
5.25%
Day range:
$93.74 - $96.39
52-week range:
$89.14 - $138.49
Dividend yield:
2.58%
P/E ratio:
14.45x
P/S ratio:
1.14x
P/B ratio:
1.49x
Volume:
38.2K
Avg. volume:
62.3K
1-year change:
3.98%
Market cap:
$1.5B
Revenue:
$1.3B
EPS (TTM):
$6.54

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
NHC
National Healthcare
-- -- -- -- --
AGL
Agilon Health
$1.5B $0.01 -6.23% -86.8% $4.32
AMS
American Shared Hospital Services
$8.6M $0.04 18.76% -92.73% $4.84
CCEL
Cryo-Cell International
$7.9M $0.01 -0.02% -62.5% $8.50
INNV
InnovAge Holding
$214.1M -- 10.89% -100% $5.25
SNDA
Sonida Senior Living
-- -- -- -- $25.00
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
NHC
National Healthcare
$94.49 -- $1.5B 14.45x $0.61 2.58% 1.14x
AGL
Agilon Health
$4.26 $4.32 $1.8B -- $0.00 0% 0.29x
AMS
American Shared Hospital Services
$2.70 $4.84 $17.4M 7.94x $0.00 0% 0.64x
CCEL
Cryo-Cell International
$5.25 $8.50 $42.4M 525.00x $0.25 9.52% 1.34x
INNV
InnovAge Holding
$3.13 $5.25 $423.3M -- $0.00 0% 0.53x
SNDA
Sonida Senior Living
$23.22 $25.00 $439.2M -- $0.00 0% 1.09x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
NHC
National Healthcare
12.26% 1.486 8.8% 1.50x
AGL
Agilon Health
6.9% -0.735 4.46% 1.23x
AMS
American Shared Hospital Services
45.9% 0.640 90.05% 1.35x
CCEL
Cryo-Cell International
-796.74% 1.979 20.39% 0.49x
INNV
InnovAge Holding
20.38% 1.655 11.33% 0.97x
SNDA
Sonida Senior Living
84.11% -0.145 131.29% 0.48x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
NHC
National Healthcare
$135M $28.9M 10.11% 10.72% 2.28% $4.6M
AGL
Agilon Health
-$38.3M -$104.5M -40.06% -42.35% -6.77% $4M
AMS
American Shared Hospital Services
$1.4M -$553K 8.36% 13.75% -3.47% -$407K
CCEL
Cryo-Cell International
$6M $1.1M 122.88% -- 12.91% $892K
INNV
InnovAge Holding
$37.1M -$4.1M -7.17% -8.76% -6.08% $5.4M
SNDA
Sonida Senior Living
$220.8M -$6.4M -0.32% -4.58% 3.73% -$10.4M

National Healthcare vs. Competitors

  • Which has Higher Returns NHC or AGL?

    Agilon Health has a net margin of 1.65% compared to National Healthcare's net margin of -6.95%. National Healthcare's return on equity of 10.72% beat Agilon Health's return on equity of -42.35%.

    Company Gross Margin Earnings Per Share Invested Capital
    NHC
    National Healthcare
    36.56% $0.39 $1.1B
    AGL
    Agilon Health
    -2.51% -$0.26 $505.9M
  • What do Analysts Say About NHC or AGL?

    National Healthcare has a consensus price target of --, signalling downside risk potential of --. On the other hand Agilon Health has an analysts' consensus of $4.32 which suggests that it could grow by 1.36%. Given that Agilon Health has higher upside potential than National Healthcare, analysts believe Agilon Health is more attractive than National Healthcare.

    Company Buy Ratings Hold Ratings Sell Ratings
    NHC
    National Healthcare
    0 0 0
    AGL
    Agilon Health
    4 15 0
  • Is NHC or AGL More Risky?

    National Healthcare has a beta of 0.512, which suggesting that the stock is 48.765% less volatile than S&P 500. In comparison Agilon Health has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock NHC or AGL?

    National Healthcare has a quarterly dividend of $0.61 per share corresponding to a yield of 2.58%. Agilon Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. National Healthcare pays 36.27% of its earnings as a dividend. Agilon Health pays out -- of its earnings as a dividend. National Healthcare's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios NHC or AGL?

    National Healthcare quarterly revenues are $369.4M, which are smaller than Agilon Health quarterly revenues of $1.5B. National Healthcare's net income of $6.1M is higher than Agilon Health's net income of -$105.8M. Notably, National Healthcare's price-to-earnings ratio is 14.45x while Agilon Health's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National Healthcare is 1.14x versus 0.29x for Agilon Health. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NHC
    National Healthcare
    1.14x 14.45x $369.4M $6.1M
    AGL
    Agilon Health
    0.29x -- $1.5B -$105.8M
  • Which has Higher Returns NHC or AMS?

    American Shared Hospital Services has a net margin of 1.65% compared to National Healthcare's net margin of -2.96%. National Healthcare's return on equity of 10.72% beat American Shared Hospital Services's return on equity of 13.75%.

    Company Gross Margin Earnings Per Share Invested Capital
    NHC
    National Healthcare
    36.56% $0.39 $1.1B
    AMS
    American Shared Hospital Services
    19.57% -$0.03 $54.2M
  • What do Analysts Say About NHC or AMS?

    National Healthcare has a consensus price target of --, signalling downside risk potential of --. On the other hand American Shared Hospital Services has an analysts' consensus of $4.84 which suggests that it could grow by 79.26%. Given that American Shared Hospital Services has higher upside potential than National Healthcare, analysts believe American Shared Hospital Services is more attractive than National Healthcare.

    Company Buy Ratings Hold Ratings Sell Ratings
    NHC
    National Healthcare
    0 0 0
    AMS
    American Shared Hospital Services
    0 0 0
  • Is NHC or AMS More Risky?

    National Healthcare has a beta of 0.512, which suggesting that the stock is 48.765% less volatile than S&P 500. In comparison American Shared Hospital Services has a beta of 0.356, suggesting its less volatile than the S&P 500 by 64.359%.

  • Which is a Better Dividend Stock NHC or AMS?

    National Healthcare has a quarterly dividend of $0.61 per share corresponding to a yield of 2.58%. American Shared Hospital Services offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. National Healthcare pays 36.27% of its earnings as a dividend. American Shared Hospital Services pays out -- of its earnings as a dividend. National Healthcare's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios NHC or AMS?

    National Healthcare quarterly revenues are $369.4M, which are larger than American Shared Hospital Services quarterly revenues of $7M. National Healthcare's net income of $6.1M is higher than American Shared Hospital Services's net income of -$207K. Notably, National Healthcare's price-to-earnings ratio is 14.45x while American Shared Hospital Services's PE ratio is 7.94x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National Healthcare is 1.14x versus 0.64x for American Shared Hospital Services. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NHC
    National Healthcare
    1.14x 14.45x $369.4M $6.1M
    AMS
    American Shared Hospital Services
    0.64x 7.94x $7M -$207K
  • Which has Higher Returns NHC or CCEL?

    Cryo-Cell International has a net margin of 1.65% compared to National Healthcare's net margin of 3.55%. National Healthcare's return on equity of 10.72% beat Cryo-Cell International's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    NHC
    National Healthcare
    36.56% $0.39 $1.1B
    CCEL
    Cryo-Cell International
    75.1% $0.03 -$1.6M
  • What do Analysts Say About NHC or CCEL?

    National Healthcare has a consensus price target of --, signalling downside risk potential of --. On the other hand Cryo-Cell International has an analysts' consensus of $8.50 which suggests that it could grow by 61.91%. Given that Cryo-Cell International has higher upside potential than National Healthcare, analysts believe Cryo-Cell International is more attractive than National Healthcare.

    Company Buy Ratings Hold Ratings Sell Ratings
    NHC
    National Healthcare
    0 0 0
    CCEL
    Cryo-Cell International
    0 0 0
  • Is NHC or CCEL More Risky?

    National Healthcare has a beta of 0.512, which suggesting that the stock is 48.765% less volatile than S&P 500. In comparison Cryo-Cell International has a beta of 0.724, suggesting its less volatile than the S&P 500 by 27.595%.

  • Which is a Better Dividend Stock NHC or CCEL?

    National Healthcare has a quarterly dividend of $0.61 per share corresponding to a yield of 2.58%. Cryo-Cell International offers a yield of 9.52% to investors and pays a quarterly dividend of $0.25 per share. National Healthcare pays 36.27% of its earnings as a dividend. Cryo-Cell International pays out 502.5% of its earnings as a dividend. National Healthcare's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Cryo-Cell International's is not.

  • Which has Better Financial Ratios NHC or CCEL?

    National Healthcare quarterly revenues are $369.4M, which are larger than Cryo-Cell International quarterly revenues of $8M. National Healthcare's net income of $6.1M is higher than Cryo-Cell International's net income of $282.9K. Notably, National Healthcare's price-to-earnings ratio is 14.45x while Cryo-Cell International's PE ratio is 525.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National Healthcare is 1.14x versus 1.34x for Cryo-Cell International. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NHC
    National Healthcare
    1.14x 14.45x $369.4M $6.1M
    CCEL
    Cryo-Cell International
    1.34x 525.00x $8M $282.9K
  • Which has Higher Returns NHC or INNV?

    InnovAge Holding has a net margin of 1.65% compared to National Healthcare's net margin of -6.33%. National Healthcare's return on equity of 10.72% beat InnovAge Holding's return on equity of -8.76%.

    Company Gross Margin Earnings Per Share Invested Capital
    NHC
    National Healthcare
    36.56% $0.39 $1.1B
    INNV
    InnovAge Holding
    17.74% -$0.10 $341.5M
  • What do Analysts Say About NHC or INNV?

    National Healthcare has a consensus price target of --, signalling downside risk potential of --. On the other hand InnovAge Holding has an analysts' consensus of $5.25 which suggests that it could grow by 67.73%. Given that InnovAge Holding has higher upside potential than National Healthcare, analysts believe InnovAge Holding is more attractive than National Healthcare.

    Company Buy Ratings Hold Ratings Sell Ratings
    NHC
    National Healthcare
    0 0 0
    INNV
    InnovAge Holding
    0 3 0
  • Is NHC or INNV More Risky?

    National Healthcare has a beta of 0.512, which suggesting that the stock is 48.765% less volatile than S&P 500. In comparison InnovAge Holding has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock NHC or INNV?

    National Healthcare has a quarterly dividend of $0.61 per share corresponding to a yield of 2.58%. InnovAge Holding offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. National Healthcare pays 36.27% of its earnings as a dividend. InnovAge Holding pays out -- of its earnings as a dividend. National Healthcare's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios NHC or INNV?

    National Healthcare quarterly revenues are $369.4M, which are larger than InnovAge Holding quarterly revenues of $209M. National Healthcare's net income of $6.1M is higher than InnovAge Holding's net income of -$13.2M. Notably, National Healthcare's price-to-earnings ratio is 14.45x while InnovAge Holding's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National Healthcare is 1.14x versus 0.53x for InnovAge Holding. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NHC
    National Healthcare
    1.14x 14.45x $369.4M $6.1M
    INNV
    InnovAge Holding
    0.53x -- $209M -$13.2M
  • Which has Higher Returns NHC or SNDA?

    Sonida Senior Living has a net margin of 1.65% compared to National Healthcare's net margin of -5.99%. National Healthcare's return on equity of 10.72% beat Sonida Senior Living's return on equity of -4.58%.

    Company Gross Margin Earnings Per Share Invested Capital
    NHC
    National Healthcare
    36.56% $0.39 $1.1B
    SNDA
    Sonida Senior Living
    23.56% -$0.38 $781M
  • What do Analysts Say About NHC or SNDA?

    National Healthcare has a consensus price target of --, signalling downside risk potential of --. On the other hand Sonida Senior Living has an analysts' consensus of $25.00 which suggests that it could grow by 7.67%. Given that Sonida Senior Living has higher upside potential than National Healthcare, analysts believe Sonida Senior Living is more attractive than National Healthcare.

    Company Buy Ratings Hold Ratings Sell Ratings
    NHC
    National Healthcare
    0 0 0
    SNDA
    Sonida Senior Living
    0 1 0
  • Is NHC or SNDA More Risky?

    National Healthcare has a beta of 0.512, which suggesting that the stock is 48.765% less volatile than S&P 500. In comparison Sonida Senior Living has a beta of 1.143, suggesting its more volatile than the S&P 500 by 14.264%.

  • Which is a Better Dividend Stock NHC or SNDA?

    National Healthcare has a quarterly dividend of $0.61 per share corresponding to a yield of 2.58%. Sonida Senior Living offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. National Healthcare pays 36.27% of its earnings as a dividend. Sonida Senior Living pays out -136.86% of its earnings as a dividend. National Healthcare's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios NHC or SNDA?

    National Healthcare quarterly revenues are $369.4M, which are larger than Sonida Senior Living quarterly revenues of $91.9M. National Healthcare's net income of $6.1M is higher than Sonida Senior Living's net income of -$5.5M. Notably, National Healthcare's price-to-earnings ratio is 14.45x while Sonida Senior Living's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National Healthcare is 1.14x versus 1.09x for Sonida Senior Living. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NHC
    National Healthcare
    1.14x 14.45x $369.4M $6.1M
    SNDA
    Sonida Senior Living
    1.09x -- $91.9M -$5.5M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is QuantumScape a Buy Now?
Is QuantumScape a Buy Now?

QuantumScape (NYSE:QS) is an innovative EV battery company that specializes…

Is Vertex Stock Still a Good Buy?
Is Vertex Stock Still a Good Buy?

Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…

Is Okta Stock Finally Gaining Investor Confidence?
Is Okta Stock Finally Gaining Investor Confidence?

Given how digital transformation has proliferated, cyberattacks have also been…

Stock Ideas

Buy
61
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
58
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Sell
50
RGC alert for May 1

Regencell Bioscience Holdings [RGC] is up 6.67% over the past day.

Sell
38
WGS alert for May 1

GeneDx Holdings [WGS] is down 3.52% over the past day.

Sell
43
VICR alert for May 1

Vicor [VICR] is up 0.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock